Axsome Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. Welcome to our next session here with Axsome Therapeutics. I'm Eason Lee, one of the associates on the biotech research team here at Needham. And it's my pleasure to be hosting Herriot Tabuteau, who is the CEO of the company. (Conference Instructions)
Questions & Answers
Herriot, thank you so much for joining today. And maybe to start off, it would be great if you could provide some introductory comments about the key elements of the company's strategy. What are some of the things we should be watching for in 2023?
Great. Thank you so much, Eason, for having us present at the Needham Conference. We always enjoy presenting at Needham. So it's nice to continue that tradition, which I think we've been doing ever since we went public.
And right now, Axsome has entered into a very exciting phase for the company. If you step back,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
